UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 30, 2021
Accession Number:
Submission Type:
CIK: 0001372514
Company Name: EYEGATE PHARMACEUTICALS INC
File Number: 333-255311